首页> 美国卫生研究院文献>British Journal of Clinical Pharmacology >The effects of lisuride terguride and bromocriptine on intraocular pressure (IOP).
【2h】

The effects of lisuride terguride and bromocriptine on intraocular pressure (IOP).

机译:异丁环脲特古瑞特和溴隐亭对眼内压(IOP)的影响。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

1. The effects of a single oral dose of the dopaminergic agonists lisuride (0.1 mg), terguride (0.25 mg) and bromocriptine (1.25 mg) on IOP were studied in eight normal volunteers using the non-contact tonometer. 2. Considering all post-dose measurements, compared with placebo, bromocriptine and lisuride but not terguride reduced IOP significantly in both eyes. 3. There was no significant difference between the ocular hypotensive effect of bromocriptine and lisuride. 4. Terguride reduced IOP significantly in the left eye at the 3 h time point after drug administration. 5. The result of this study confirms the reported ocular hypotensive effect of bromocriptine and showed that lisuride is as effective as bromocriptine in reducing IOP. 6. To evaluate the clinical importance of these drugs as ocular hypotensive agents other studies are needed using eye drops.
机译:1.在八名正常志愿者中,使用非接触式眼压计研究了单次口服剂量的多巴胺能激动剂lisuride(0.1 mg),terguride(0.25 mg)和溴隐亭(1.25 mg)对IOP的影响。 2.考虑到所有给药后的测量结果,与安慰剂相比,溴隐亭和利舒利特但特格列胺并未显着降低两只眼睛的IOP。 3.溴隐亭和利舒利特的降眼压作用无明显差异。 4.在给药后3小时的时间点,Terguride显着降低了左眼的IOP。 5.这项研究的结果证实了溴隐亭的降眼压作用,并显示利苏利特与溴隐亭在降低IOP方面同样有效。 6.为了评估这些药物作为降压药的临床重要性,还需要使用滴眼剂进行其他研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号